Ethnicity, genomic ancestry, and HBV genotype in off-treatment outcomes following nucleos(t)ide analogue cessation : a prospective multicentre trial (COIN-B)
Source
Nature communications - ISSN 2041-1723- (2026) p. 1-13
From targets to real world impact : a review of models of care for chronic HBV and HCV in Europe
Source
The Lancet regional health. Europe - ISSN 2666-7762-65 (2026) p.
A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells
Source
JHEP Reports - ISSN 2589-5559-8:4 (2026) p. 1-11
Clinical trial : hepatitis B virus genotype and a combination of end‐of‐treatment biomarkers predict severe flares after nucleos(t)ide analogue cessation
Source
Alimentary pharmacology and therapeutics - ISSN 0269-2813-63:3 (2026) p. 352-361
Opportunistic screening using point-of-care testing leads to successful linkage to care of HBV-infected migrant populations in a low endemic country
Source
Journal of virus eradication - ISSN 2055-6640-10 (2024) p. 1-6